Reversible opacification of a hydrophilic acrylic intraocular lens

Choul Yong Park, Roy S. Chuck

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

A 56-year-old woman with diabetic retinopathy and chronic myelogenous leukemia had phacoemulsification cataract removal and hydrophilic acrylic intraocular lens (IOL) (Akreos MI-60) implantation in both eyes. One month after surgery, significant IOL opacity and severe cystoid macular edema were observed in both eyes. After bilateral intravitreal injection of bevacizumab (Avastin) to control macular edema, central clearing of the IOL opacity was observed in both eyes. Two months after the injection, the IOL opacity had almost disappeared from both eyes. To our knowledge, this is the first case of early postoperative bilateral IOL opacity in a hydrophilic acrylic IOL cleared after anti-vascular endothelial growth factor (VEGF) intravitreal injection. The role of anti-VEGF therapy in clearing IOL opacification requires further investigation. Financial Disclosure: Neither author has a financial or proprietary interest in any material or method mentioned.

Original languageEnglish (US)
Pages (from-to)166-169
Number of pages4
JournalJournal of Cataract and Refractive Surgery
Volume38
Issue number1
DOIs
StatePublished - Jan 2012

Fingerprint

Intraocular Lenses
Cataract
Intravitreal Injections
Macular Edema
Vascular Endothelial Growth Factor A
Phacoemulsification
Disclosure
Diabetic Retinopathy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Injections

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Surgery

Cite this

Reversible opacification of a hydrophilic acrylic intraocular lens. / Park, Choul Yong; Chuck, Roy S.

In: Journal of Cataract and Refractive Surgery, Vol. 38, No. 1, 01.2012, p. 166-169.

Research output: Contribution to journalArticle

@article{a562f9291b8c4fa7910604863c0b5c62,
title = "Reversible opacification of a hydrophilic acrylic intraocular lens",
abstract = "A 56-year-old woman with diabetic retinopathy and chronic myelogenous leukemia had phacoemulsification cataract removal and hydrophilic acrylic intraocular lens (IOL) (Akreos MI-60) implantation in both eyes. One month after surgery, significant IOL opacity and severe cystoid macular edema were observed in both eyes. After bilateral intravitreal injection of bevacizumab (Avastin) to control macular edema, central clearing of the IOL opacity was observed in both eyes. Two months after the injection, the IOL opacity had almost disappeared from both eyes. To our knowledge, this is the first case of early postoperative bilateral IOL opacity in a hydrophilic acrylic IOL cleared after anti-vascular endothelial growth factor (VEGF) intravitreal injection. The role of anti-VEGF therapy in clearing IOL opacification requires further investigation. Financial Disclosure: Neither author has a financial or proprietary interest in any material or method mentioned.",
author = "Park, {Choul Yong} and Chuck, {Roy S.}",
year = "2012",
month = "1",
doi = "10.1016/j.jcrs.2011.08.027",
language = "English (US)",
volume = "38",
pages = "166--169",
journal = "Journal of Cataract and Refractive Surgery",
issn = "0886-3350",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Reversible opacification of a hydrophilic acrylic intraocular lens

AU - Park, Choul Yong

AU - Chuck, Roy S.

PY - 2012/1

Y1 - 2012/1

N2 - A 56-year-old woman with diabetic retinopathy and chronic myelogenous leukemia had phacoemulsification cataract removal and hydrophilic acrylic intraocular lens (IOL) (Akreos MI-60) implantation in both eyes. One month after surgery, significant IOL opacity and severe cystoid macular edema were observed in both eyes. After bilateral intravitreal injection of bevacizumab (Avastin) to control macular edema, central clearing of the IOL opacity was observed in both eyes. Two months after the injection, the IOL opacity had almost disappeared from both eyes. To our knowledge, this is the first case of early postoperative bilateral IOL opacity in a hydrophilic acrylic IOL cleared after anti-vascular endothelial growth factor (VEGF) intravitreal injection. The role of anti-VEGF therapy in clearing IOL opacification requires further investigation. Financial Disclosure: Neither author has a financial or proprietary interest in any material or method mentioned.

AB - A 56-year-old woman with diabetic retinopathy and chronic myelogenous leukemia had phacoemulsification cataract removal and hydrophilic acrylic intraocular lens (IOL) (Akreos MI-60) implantation in both eyes. One month after surgery, significant IOL opacity and severe cystoid macular edema were observed in both eyes. After bilateral intravitreal injection of bevacizumab (Avastin) to control macular edema, central clearing of the IOL opacity was observed in both eyes. Two months after the injection, the IOL opacity had almost disappeared from both eyes. To our knowledge, this is the first case of early postoperative bilateral IOL opacity in a hydrophilic acrylic IOL cleared after anti-vascular endothelial growth factor (VEGF) intravitreal injection. The role of anti-VEGF therapy in clearing IOL opacification requires further investigation. Financial Disclosure: Neither author has a financial or proprietary interest in any material or method mentioned.

UR - http://www.scopus.com/inward/record.url?scp=83555176167&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=83555176167&partnerID=8YFLogxK

U2 - 10.1016/j.jcrs.2011.08.027

DO - 10.1016/j.jcrs.2011.08.027

M3 - Article

C2 - 22074677

AN - SCOPUS:83555176167

VL - 38

SP - 166

EP - 169

JO - Journal of Cataract and Refractive Surgery

JF - Journal of Cataract and Refractive Surgery

SN - 0886-3350

IS - 1

ER -